Insulin glargine and lixisenatide Subcutaneous and Panobinostat Lactate
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Panobinostat Lactate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: panobinostat
Brand name: Farydak
Synonyms: Panobinostat
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Panocaps
- Insulin glargine and lixisenatide Subcutaneous-PanOxyl
- Insulin glargine and lixisenatide Subcutaneous-Panoxyl Soap
- Insulin glargine and lixisenatide Subcutaneous-PanOxyl Wash
- Insulin glargine and lixisenatide Subcutaneous-PanOxyl-4 Creamy Wash
- Insulin glargine and lixisenatide Subcutaneous-PanOxyl-8 Creamy Wash
- Panobinostat Lactate-Insulin glargine, recombinant Subcutaneous
- Panobinostat Lactate-Insulin glulisine
- Panobinostat Lactate-Insulin Glulisine (Cartridges and Pens)
- Panobinostat Lactate-Insulin Glulisine (Vials)
- Panobinostat Lactate-Insulin glulisine Subcutaneous
- Panobinostat Lactate-Insulin human inhaled Inhalation